Academia Europaea has named DZD executive board member Prof. Dr. Michael Roden as a new member for the research fields of endocrinology and diabetology.

“I am delighted to have been considered, especially because being elected as a member of Academia Europaea is further recognition of the achievements of my institute at the DDZ and my department at UKD,” explains Prof. Dr. Roden.

Prof. Dr. Roden has authored or co-authored more than 700 scientific publications. His main research topics include precision diabetes medicine, the onset and course of non-alcoholic fatty liver disease (NAFLD), and energy metabolism in people with diabetes and obesity. From 2000 to 2005, he was president of the Austrian Diabetes Association, from 2009 to 2013, he was president of the Central European Diabetes Association (CEDA-FID), serving as a board member until 2022, and, from 2020 to 2021, he was chairman of the European Foundation for the Study of Diabetes (EFSD) and board member at the European Association for the Study of Diabetes (EASD). He is an honorary member of the Hungarian Diabetes Association and holds honorary doctorate titles from the Universities of Athens and Belgrade.

The stated aim of Academia Europaea, which was founded in 1988, is to act as an independent European association for the benefit of all: “Aiming to promote European research, provide scientific advice to governments and international organizations, and further interdisciplinary and international research.” Research in the natural and social sciences and the humanities is taken into consideration. Membership is granted by the specialist group via a strict peer-review selection process.